Navigation Links
The Mattson Jack Group, Inc. Announces the Release of the New Comorbidity Database(TM)
Date:10/26/2007

ST. LOUIS, Oct. 26 /PRNewswire/ -- The Mattson Jack Group, Inc. (MattsonJack) announces the release of its Comorbidity Database(TM).

Comorbidity Database(TM) is designed to help clients make strategic decisions based on an in-depth understanding of the importance of mutually exclusive and overlapping conditions. Comorbidity Database(TM) consists of two modules: Comorbidity Database(TM) -- CNS 2.0, which focuses on mental health disorders, and Comorbidity Database(TM) -- Med 2.0, which features a broad range of medical diagnoses and risk factors, excluding mental health disorders.

The Comorbidity Database(TM) will provide patient numbers for mutually exclusive segments for any combination of disorders / diagnostic categories. "Pharmaceutical companies can use this information to build accurate market forecasts, identify patient subgroups by various risk factors, and analyze overlaps of subgroup populations," said David Robinson, Director of Epidemiology at MattsonJack.

The Comorbidity Database(TM) product offerings exemplify MattsonJack's commitment to epidemiology and continuous product enhancement. Additional information on disorders or conditions covered by each module, data sources, and additional enhancements can be found on MattsonJack's website: Comorbidity Database(TM). To arrange a personal demonstration of the Comorbidity Database(TM), e-mail Deborah Hammonds, or telephone 314.529.3064.

About The Mattson Jack Group, Inc. (http://www.mattsonjack.com)

Formed in 1986, MattsonJack focuses its client support in three areas of Competency: Business Analytics, Brand Optimization, and Corporate Development services in the pharmaceutical and biotech markets.

MattsonJack's knowledgeware and client productivity tools include Epi Database(R) and Forecast Architect(R). Additionally, MattsonJack, as one of the largest global oncology consulting firms, supports its clients' cancer interests through its MattsonJack DaVinci multiclient offerings, including CancerMPact(R), Oncology Marketing Strategies(TM), Supportive Care Perspectives(TM), and its Future Focus(TM) series Myelodysplastic Syndromes (MDS) and Gastrointestinal Stromal Tumor (GIST).

About Kantar Group (http://www.kantargroup.com)

Kantar is one of the world's largest research, insight, and consultancy networks. It helps clients make better business decisions through a deeper understanding of their markets, their brands, and their customers. Part of WPP, Kantar brings together a diverse group of outstanding marketing insight and consulting companies -- each an expert in their field who can work together seamlessly to help clients address business issues in a holistic and strategic way.

Companies include Added Value Group, IMRB, BMRB, BPRI, Cannondale Associates, Center Partners, Everystone, Focalyst, Fusion 5, Glendinning Management Consultants, Henley Centre HeadlightVision, IMRB, Kantar Operations, KMR Group, Lightspeed Research, Management Ventures, MattsonJack Group, Millward Brown, Research International, RMS and Ziment Group. The group operates in more than 160 offices across 60 markets worldwide.


'/>"/>
SOURCE The Mattson Jack Group, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... 2017 , ... The Bryant Agency, a Georgia based firm ... in the Dalton region, is working in conjunction with the GreenHouse organization in ... abuse. , The GreenHouse is headquartered in Dalton and provides a refuge for ...
(Date:7/21/2017)... , ... July 21, 2017 , ... ... assistance and financial planning services to communities in the greater Birmingham area, is ... provide resources to underprivileged young people in the region. , The Chris Hammond ...
(Date:7/21/2017)... ... , ... Hospital M&A activity slowed in the second quarter of 2017, according ... to 23 in the second quarter, up 15% from the 20 publicly announced acquisitions ... in the year-ago second quarter. Only four of the transactions disclosed a purchase price ...
(Date:7/21/2017)... ... July 21, 2017 , ... The ... grant from the C. R. Bard Foundation, Inc. to support the ... , a service available through the nonprofit home care agency. Using evidence-based methods, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased to announce the ... July 17, 2017, Ms. Vu will join West Dermatology’s large network of medical and ... skin cancer , and more. She graduated from the University of Florida College ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... , July 11, 2017 Oramed Pharmaceuticals ... a clinical-stage pharmaceutical company focused on the development of ... Food and Drug Administration (FDA) has agreed to schedule ... completed Phase IIb trial of its oral insulin capsule ... Phase IIb trial met primary and secondary endpoints by ...
(Date:7/10/2017)... CARLSBAD, Calif. , July 10, 2017  The ... in Boston, MA at the ... unequaled value and unparalleled access to global decision makers ... to draw 800+ life science leaders during two impactful ... Boston, and provides delegates with additional networking opportunities with ...
(Date:7/5/2017)... JERUSALEM , July 5, 2017 ... www.oramed.com ), a clinical-stage pharmaceutical company ... today that it has received approval from the Israel Securities ... Stock Exchange (TASE). Oramed common stock will commence trading on ... Based on the current market capitalization of the Company, it ...
Breaking Medicine Technology: